Molecular Modeling and Prediction of Bioactivity:
Much of chemistry, molecular biology, and drug design, are centered around the relationships between chemical structure and measured properties of compounds and polymers, such as viscosity, acidity, solubility, toxicity, enzyme binding, and membrane penetration. For any set of compounds, these relat...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Boston, MA
Springer US
2000
|
Schlagworte: | |
Online-Zugang: | UBT01 URL des Erstveröffentlichers |
Zusammenfassung: | Much of chemistry, molecular biology, and drug design, are centered around the relationships between chemical structure and measured properties of compounds and polymers, such as viscosity, acidity, solubility, toxicity, enzyme binding, and membrane penetration. For any set of compounds, these relationships are by necessity complicated, particularly when the properties are of biological nature. To investigate and utilize such complicated relationships, henceforth abbreviated SAR for structure-activity relationships, and QSAR for quantitative SAR, we need a description of the variation in chemical structure of relevant compounds and biological targets, good measures of the biological properties, and, of course, an ability to synthesize compounds of interest. In addition, we need reasonable ways to construct and express the relationships, i. e. , mathematical or other models, as well as ways to select the compounds to be investigated so that the resulting QSAR indeed is informative and useful for the stated purposes. In the present context, these purposes typically are the conceptual understanding of the SAR, and the ability to propose new compounds with improved property profiles. Here we discuss the two latter parts of the SARlQSAR problem, i. e. , reasonable ways to model the relationships, and how to select compounds to make the models as "good" as possible. The second is often called the problem of statistical experimental design, which in the present context we call statistical molecular design, SMD. 1 |
Beschreibung: | 1 Online-Ressource (XVI, 502 p) |
ISBN: | 9781461541417 |
DOI: | 10.1007/978-1-4615-4141-7 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV045151878 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 180828s2000 |||| o||u| ||||||eng d | ||
020 | |a 9781461541417 |9 978-1-4615-4141-7 | ||
024 | 7 | |a 10.1007/978-1-4615-4141-7 |2 doi | |
035 | |a (ZDB-2-CMS)978-1-4615-4141-7 | ||
035 | |a (OCoLC)1184268106 | ||
035 | |a (DE-599)BVBBV045151878 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-703 | ||
082 | 0 | |a 541.0285 |2 23 | |
245 | 1 | 0 | |a Molecular Modeling and Prediction of Bioactivity |c edited by Klaus Gundertofte, Flemming Steen Jørgensen |
264 | 1 | |a Boston, MA |b Springer US |c 2000 | |
300 | |a 1 Online-Ressource (XVI, 502 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a Much of chemistry, molecular biology, and drug design, are centered around the relationships between chemical structure and measured properties of compounds and polymers, such as viscosity, acidity, solubility, toxicity, enzyme binding, and membrane penetration. For any set of compounds, these relationships are by necessity complicated, particularly when the properties are of biological nature. To investigate and utilize such complicated relationships, henceforth abbreviated SAR for structure-activity relationships, and QSAR for quantitative SAR, we need a description of the variation in chemical structure of relevant compounds and biological targets, good measures of the biological properties, and, of course, an ability to synthesize compounds of interest. In addition, we need reasonable ways to construct and express the relationships, i. e. , mathematical or other models, as well as ways to select the compounds to be investigated so that the resulting QSAR indeed is informative and useful for the stated purposes. In the present context, these purposes typically are the conceptual understanding of the SAR, and the ability to propose new compounds with improved property profiles. Here we discuss the two latter parts of the SARlQSAR problem, i. e. , reasonable ways to model the relationships, and how to select compounds to make the models as "good" as possible. The second is often called the problem of statistical experimental design, which in the present context we call statistical molecular design, SMD. 1 | ||
650 | 4 | |a Chemistry | |
650 | 4 | |a Computer Applications in Chemistry | |
650 | 4 | |a Pharmacy | |
650 | 4 | |a Biochemistry, general | |
650 | 4 | |a Chemistry | |
650 | 4 | |a Pharmacy | |
650 | 4 | |a Chemoinformatics | |
650 | 4 | |a Biochemistry | |
650 | 0 | 7 | |a Bioaktive Verbindungen |0 (DE-588)4145589-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a QSAR |0 (DE-588)4205429-1 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1998 |z Kopenhagen |2 gnd-content | |
689 | 0 | 0 | |a QSAR |0 (DE-588)4205429-1 |D s |
689 | 0 | 1 | |a Bioaktive Verbindungen |0 (DE-588)4145589-7 |D s |
689 | 0 | |8 2\p |5 DE-604 | |
700 | 1 | |a Gundertofte, Klaus |4 edt | |
700 | 1 | |a Jørgensen, Flemming Steen |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461368571 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-4141-7 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-CMS | ||
940 | 1 | |q ZDB-2-CMS_2000/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-030541546 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-1-4615-4141-7 |l UBT01 |p ZDB-2-CMS |q ZDB-2-CMS_2000/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178824409120768 |
---|---|
any_adam_object | |
author2 | Gundertofte, Klaus Jørgensen, Flemming Steen |
author2_role | edt edt |
author2_variant | k g kg f s j fs fsj |
author_facet | Gundertofte, Klaus Jørgensen, Flemming Steen |
building | Verbundindex |
bvnumber | BV045151878 |
collection | ZDB-2-CMS |
ctrlnum | (ZDB-2-CMS)978-1-4615-4141-7 (OCoLC)1184268106 (DE-599)BVBBV045151878 |
dewey-full | 541.0285 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 541 - Physical chemistry |
dewey-raw | 541.0285 |
dewey-search | 541.0285 |
dewey-sort | 3541.0285 |
dewey-tens | 540 - Chemistry and allied sciences |
discipline | Chemie / Pharmazie |
doi_str_mv | 10.1007/978-1-4615-4141-7 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03616nmm a2200565zc 4500</leader><controlfield tag="001">BV045151878</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180828s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461541417</subfield><subfield code="9">978-1-4615-4141-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-4141-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-CMS)978-1-4615-4141-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1184268106</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045151878</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">541.0285</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular Modeling and Prediction of Bioactivity</subfield><subfield code="c">edited by Klaus Gundertofte, Flemming Steen Jørgensen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVI, 502 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Much of chemistry, molecular biology, and drug design, are centered around the relationships between chemical structure and measured properties of compounds and polymers, such as viscosity, acidity, solubility, toxicity, enzyme binding, and membrane penetration. For any set of compounds, these relationships are by necessity complicated, particularly when the properties are of biological nature. To investigate and utilize such complicated relationships, henceforth abbreviated SAR for structure-activity relationships, and QSAR for quantitative SAR, we need a description of the variation in chemical structure of relevant compounds and biological targets, good measures of the biological properties, and, of course, an ability to synthesize compounds of interest. In addition, we need reasonable ways to construct and express the relationships, i. e. , mathematical or other models, as well as ways to select the compounds to be investigated so that the resulting QSAR indeed is informative and useful for the stated purposes. In the present context, these purposes typically are the conceptual understanding of the SAR, and the ability to propose new compounds with improved property profiles. Here we discuss the two latter parts of the SARlQSAR problem, i. e. , reasonable ways to model the relationships, and how to select compounds to make the models as "good" as possible. The second is often called the problem of statistical experimental design, which in the present context we call statistical molecular design, SMD. 1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Computer Applications in Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemoinformatics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bioaktive Verbindungen</subfield><subfield code="0">(DE-588)4145589-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">QSAR</subfield><subfield code="0">(DE-588)4205429-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1998</subfield><subfield code="z">Kopenhagen</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">QSAR</subfield><subfield code="0">(DE-588)4205429-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Bioaktive Verbindungen</subfield><subfield code="0">(DE-588)4145589-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gundertofte, Klaus</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jørgensen, Flemming Steen</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461368571</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-4141-7</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-CMS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-CMS_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030541546</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-4141-7</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-CMS</subfield><subfield code="q">ZDB-2-CMS_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)1071861417 Konferenzschrift 1998 Kopenhagen gnd-content |
genre_facet | Konferenzschrift 1998 Kopenhagen |
id | DE-604.BV045151878 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:10:06Z |
institution | BVB |
isbn | 9781461541417 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030541546 |
oclc_num | 1184268106 |
open_access_boolean | |
owner | DE-703 |
owner_facet | DE-703 |
physical | 1 Online-Ressource (XVI, 502 p) |
psigel | ZDB-2-CMS ZDB-2-CMS_2000/2004 ZDB-2-CMS ZDB-2-CMS_2000/2004 |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | Springer US |
record_format | marc |
spelling | Molecular Modeling and Prediction of Bioactivity edited by Klaus Gundertofte, Flemming Steen Jørgensen Boston, MA Springer US 2000 1 Online-Ressource (XVI, 502 p) txt rdacontent c rdamedia cr rdacarrier Much of chemistry, molecular biology, and drug design, are centered around the relationships between chemical structure and measured properties of compounds and polymers, such as viscosity, acidity, solubility, toxicity, enzyme binding, and membrane penetration. For any set of compounds, these relationships are by necessity complicated, particularly when the properties are of biological nature. To investigate and utilize such complicated relationships, henceforth abbreviated SAR for structure-activity relationships, and QSAR for quantitative SAR, we need a description of the variation in chemical structure of relevant compounds and biological targets, good measures of the biological properties, and, of course, an ability to synthesize compounds of interest. In addition, we need reasonable ways to construct and express the relationships, i. e. , mathematical or other models, as well as ways to select the compounds to be investigated so that the resulting QSAR indeed is informative and useful for the stated purposes. In the present context, these purposes typically are the conceptual understanding of the SAR, and the ability to propose new compounds with improved property profiles. Here we discuss the two latter parts of the SARlQSAR problem, i. e. , reasonable ways to model the relationships, and how to select compounds to make the models as "good" as possible. The second is often called the problem of statistical experimental design, which in the present context we call statistical molecular design, SMD. 1 Chemistry Computer Applications in Chemistry Pharmacy Biochemistry, general Chemoinformatics Biochemistry Bioaktive Verbindungen (DE-588)4145589-7 gnd rswk-swf QSAR (DE-588)4205429-1 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1998 Kopenhagen gnd-content QSAR (DE-588)4205429-1 s Bioaktive Verbindungen (DE-588)4145589-7 s 2\p DE-604 Gundertofte, Klaus edt Jørgensen, Flemming Steen edt Erscheint auch als Druck-Ausgabe 9781461368571 https://doi.org/10.1007/978-1-4615-4141-7 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Molecular Modeling and Prediction of Bioactivity Chemistry Computer Applications in Chemistry Pharmacy Biochemistry, general Chemoinformatics Biochemistry Bioaktive Verbindungen (DE-588)4145589-7 gnd QSAR (DE-588)4205429-1 gnd |
subject_GND | (DE-588)4145589-7 (DE-588)4205429-1 (DE-588)1071861417 |
title | Molecular Modeling and Prediction of Bioactivity |
title_auth | Molecular Modeling and Prediction of Bioactivity |
title_exact_search | Molecular Modeling and Prediction of Bioactivity |
title_full | Molecular Modeling and Prediction of Bioactivity edited by Klaus Gundertofte, Flemming Steen Jørgensen |
title_fullStr | Molecular Modeling and Prediction of Bioactivity edited by Klaus Gundertofte, Flemming Steen Jørgensen |
title_full_unstemmed | Molecular Modeling and Prediction of Bioactivity edited by Klaus Gundertofte, Flemming Steen Jørgensen |
title_short | Molecular Modeling and Prediction of Bioactivity |
title_sort | molecular modeling and prediction of bioactivity |
topic | Chemistry Computer Applications in Chemistry Pharmacy Biochemistry, general Chemoinformatics Biochemistry Bioaktive Verbindungen (DE-588)4145589-7 gnd QSAR (DE-588)4205429-1 gnd |
topic_facet | Chemistry Computer Applications in Chemistry Pharmacy Biochemistry, general Chemoinformatics Biochemistry Bioaktive Verbindungen QSAR Konferenzschrift 1998 Kopenhagen |
url | https://doi.org/10.1007/978-1-4615-4141-7 |
work_keys_str_mv | AT gundertofteklaus molecularmodelingandpredictionofbioactivity AT jørgensenflemmingsteen molecularmodelingandpredictionofbioactivity |